We observed increased miR-342 expression in AML samples, especially in patients without a FLT3 mutation, compared to healthy BM-derived mononuclear cells that did not reach statistical significance ( P = 0.06; Fig. 6c ).
← all excerpts
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision.
1
0.0600
0.0600